(Q38507508)

3 September 2017

title

Are PEGylated liposomes better than conventional liposomes? A special case for vincristine (English)

1 reference

3 September 2017

Xuling Wang

1

1 reference

3 September 2017

Yanzhi Song

2

1 reference

3 September 2017

Yuqing Su

3

1 reference

3 September 2017

Qingjing Tian

4

1 reference

3 September 2017

Boqun Li

5

1 reference

3 September 2017

Jingjing Quan

6

1 reference

3 September 2017

Yihui Deng

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

29 May 2015

1 reference

3 September 2017

1 reference

3 September 2017

volume

23

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

1092-1100

1 reference

The effect of nanoparticle size, shape, and surface chemistry on biological systems

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Role of sialic acid in survival of erythrocytes in the circulation: interaction of neuraminidase-treated and untreated erythrocytes with spleen and liver at the cellular level

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Doxil®--the first FDA-approved nano-drug: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Conventional liposome performance and evaluation: lessons from the development of Vescan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Partition coefficients and their uses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Glucuronate-modified liposomes with prolonged circulation time.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

A nuclear magnetic resonance study of sphingomyelin in bilayer systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Lateral phase separation in phospholipid membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Recent advances in cancer therapy: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

PEGylation, successful approach to drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Release of drugs from liposomes varies with particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Tumor targeting of vincristine by mBAFF-modified PEG liposomes in B lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2015.1027015

10.3109/10717544.2015.1027015

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference